Currently, there are 152.87M common shares owned by the public and among those 151.44M shares have been available to trade.
The company’s stock has a 5-day price change of 5.50% and 38.37% over the past three months. It has a 12-month low price of $12.63 and touched a high of $28.68 over the same period. AHR has an average intraday trading volume of 2.18 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.90%, 11.77%, and 59.52% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of American Healthcare REIT Inc (NYSE: AHR) shares accounts for 78.93% of the company’s 152.87M shares outstanding.
It has a market capitalization of $4.57B. The earnings-per-share (ttm) stands at -$0.25. The company has a debt-to-equity ratio at 0.95. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.96% over the week and 3.67% over the month.
Earnings per share for the fiscal year are expected to increase by 101.54%, and 1219.97% over the next financial year.
Looking at the support for the AHR, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on March 14, 2024, with the firm’s price target at $18. Truist coverage for the American Healthcare REIT Inc (AHR) stock in a research note released on March 04, 2024 offered a Buy rating with a price target of $17. RBC Capital Mkts was of a view on March 04, 2024 that the stock is Outperform, while Morgan Stanley gave the stock Overweight rating on March 04, 2024, issuing a price target of $17. KeyBanc Capital Markets on their part issued Overweight rating on March 04, 2024.
